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Wayne State University researchers and colleagues, led by Zhuo-Hua Pan, Ph.D., 
professor of anatomy and cell biology in the School 
of Medicine, have reported a novel strategy for 
treatment of blinding retinal degenerative disease 
such as retinitis pigmentosa (RP). This National 
Eye Institute of the National Institutes of Health 
supported research was published in Neuron, a 
highly regarded journal which publishes reports of 
novel results in any area of the neurosciences.
A search for a cure for retinitis 
pigmentosa
Vision normally begins when rods and cones, also 
called photoreceptors, respond to light and send 
signals through other retinal neurons, inner retinal 
neurons or interneurons, and the optic nerve to 
the visual cortex of the brain where visual images 
are formed. The severe loss of photoreceptor cells 
caused by congenital retinal degenerative diseases 
results in partial or total blindness. These disease 
conditions affect one in 3,000 people worldwide. 
At present, no treatment is available for restoring 
vision once rods and cones, the normally light-
sensitive cells in the retina, have been lost.
Dr. Pan and his colleagues took a novel strategy 
for developing a potential treatment of blindness 
caused by retinal degenerative diseases by 
genetically converting light-insensitive inner retinal 
neurons into photosensitive cells – thus restoring 
light-sensitivity to retinas that lack photoreceptors. 
Using a harmless virus, they introduced a gene 
encoding a light-sensitive protein from green algae, 
called channelrhodopsin-2 (ChR2), into surviving 
inner retinal neurons in mice that were genetically 
bred to lose rods and cones, a condition similar to 
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“I’m so sorry, Mrs. Smith. Your son’s loss of night vision and decreased peripheral vision is 
caused by an inherited genetic eye disease that affects the retina called retinitis pigmentosa or RP. 
RP causes the degeneration of photoreceptor cells in the retina. It is programmed into his cells, 
and is not caused by injury or infection. Genetic mutations essentially send faulty messages to the 
retinal cells which lead to their progressive degeneration. Eventually this leads to vision loss and 
most diagnosed with RP are legally blind by age 40. Some studies suggest that treatment with 
Vitamin A may slow the progression of this disease, and current research shows some promising 
strides for future treatments, but currently there is no effective treatment for recovery of visual 
loss from RP as of today.” 
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the blinding disease, retinitis pigmentosa, 
in humans. They found that the introduced 
ChR2 protein made the inner retinal 
neurons become light sensitive. What’s 
more, they found the ChR2 protein 
persisted for long periods in these neurons, 
and the neurons generated signals that 
were transmitted to the visual cortex of the  
animals’ brains. 
“Our study demonstrates the feasibility of 
restoring visual responses in mice after they 
lose the light-sensitive photoreceptor cells,” 
said Dr. Pan. “It raises the possibility that 
this approach may be a potential strategy 
for the treatment of blindness caused by 
rod and cone degeneration in humans.” 
“With this strategy, the investigators 
have made a paradigm shift in the 
field and opened the possibility of 
genetically modifying the surviving 
retinal interneurons to function as a 
replacement light-sensing receptor,” wrote 
John Flannery and Kenneth Greenberg 
of University of California, Berkeley, in 
a preview of the paper in the same issue 
of Neuron. “This publication is clearly a 
significant first step into this new field 
of re-engineering retinal interneurons as 
genetically modified ‘prosthetic’ cells,” they 
wrote.
“This innovative gene-transfer approach 
is certainly compelling,” said Paul A. 
Sieving, M.D., Ph.D., director of vision 
research at the National Institutes of 
Health. “This is a clever approach that 
offers the possibility of some extent of 
vision restoration at some time in the 
future.”
Dr. Pan and his colleagues are working 
to determine whether the light signals 
reaching the visual cortex can be perceived 
by the brain as useful vision. They are 
also making a number of technical 
improvements to better fit the need 
for vision restoration, for example, by 
selectively targeting ChR2 in certain 
populations of inner retinal neurons and 
using other similar light sensitive proteins 
to increase light sensitivity and restore  
both ON and OFF pathways in the  
diseased retina. 
This research is providing many people 
with hope that one day there will be a 
treatment for restoring vision to those 
afflicted with RP. 
About Dr. Zhuo-Hua Pan: Dr. Pan received 
his B.S. degree from the University of Science & 
Technology of China, his M.S. from the Institute of 
Biophysics at the Chinese Academy of Science, and 
his Ph.D. from the State University of New York at 
Buffalo. He joined Wayne State University in 1999.
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